Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Cell. Neurosci.

Sec. Non-Neuronal Cells

Volume 19 - 2025 | doi: 10.3389/fncel.2025.1685491

Aquaporin-4 in Glioblastoma: From Perivascular Disruption to Edema, Immune Evasion, and Therapy Resistance

Provisionally accepted
  • Children's Hospital of Orange County, Orange, United States

The final, formatted version of the article will be published soon.

Glioblastoma (GBM) progression is linked to aquaporin-4 (AQP4), whose functions extend beyond water transport to influence perivascular architecture, immune modulation, edema, and treatment response. In the healthy brain, AQP4 is highly polarized at astrocytic endfeet, supporting perivascular fluid exchange and glymphatic clearance. In GBM, AQP4 is frequently upregulated and mislocalized, correlating with blood–brain barrier (BBB) disruption, impaired directional fluid movement, and peritumoral edema. Peritumoral astrocytic mislocalization of AQP4, together with tumor mass effect, compromises glymphatic function by distorting perivascular spaces and compressing cerebrospinal fluid (CSF)- Interstitial fluid (ISF) exchange zones. We review evidence that AQP4 isoforms (M1 vs M23) differentially shape motility and membrane organization, and we outline how AQP4-linked signaling axes (e.g., indoleamine 2,3-dioxygenase 1 (IDO1)/tryptophan 2,3-dioxygenase (TDO)-kynurenine–aryl hydrocarbon receptor (AhR) can bias pro-invasive states and immunosuppressive niches enriched with M2-like macrophages. We integrate a four-zone perivascular framework to localize where GBM most perturbs periarterial and perivenous pathways, as well as meningeal lymphatic outflow. Finally, we discuss therapeutic directions spanning AQP4 modulation, isoform balance, and BBB-bypassing delivery strategies. Overall, AQP4 emerges as a mechanistic hub connecting BBB instability, glymphatic impairment, edema, immune evasion, and invasion in GBM.

Keywords: AQP4, Glioblastoma, Glioma, Glymphatic system, astrocyte

Received: 14 Aug 2025; Accepted: 20 Oct 2025.

Copyright: © 2025 Castaneyra-Ruiz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Leandro Castaneyra-Ruiz, leandro.castaneyra.ruiz@choc.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.